This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the IIT Research Institute (IITRI), a non-profit preclinical contract research organization (CRO). The contract, with a potential value of $79,500.00, is for vaccine efficacy testing in a mouse model of H7 influenza infection. IITRI has extensive experience conducting preclinical drug development services, including pharmacology, toxicology, and efficacy studies, for federal agencies like NIH under various indefinite delivery/indefinite quantity (IDIQ) contract vehicles. This contract is not associated with a set-aside program.